In re Sulkowski

487 F.2d 920, 180 U.S.P.Q. (BNA) 46, 1973 CCPA LEXIS 237
CourtCourt of Customs and Patent Appeals
DecidedDecember 6, 1973
DocketPatent Appeal No. 9038
StatusPublished

This text of 487 F.2d 920 (In re Sulkowski) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Sulkowski, 487 F.2d 920, 180 U.S.P.Q. (BNA) 46, 1973 CCPA LEXIS 237 (ccpa 1973).

Opinion

BALDWIN, Judge.

This is an appeal from the decision of the Board of Appeals sustaining the rejection of claims 22, 23, 24 and 25 of appellant’s application1 under 35 U.S.C. § 102(e) of Houlihan patent No. 3,334,113, issued August 1, 1967, on an application filed December 18, 1963. The appealed claims were copied from Houlihan for purposes of interference2 Appellant’s application having been filed later than Houlihan, the question is whether the appealed claims of that application are entitled to the benefit of the filing date of application serial No. 272,216, filed April 11, 1963, of which it is a continuation-in-part.

Claims 22 and 24 are illustrative:

22. 9b - phenyl - 1,2,3,9b - tetrahy-dro - 5H - imidazo [2,1-a] isoindol - 5 - one.
24. A process for preparing a 9b-phenyl - 1,2,3,9b - tetrahydro - 5H - imidazo [2,1-a]. isoindol-5-one which comprises contacting an o-benzoylben-zoic acid, in an inert solvent, with a diamine of the formula H2N(CHR)2 NH2, wherein each R is, independently, hydrogen or lower alkyl, and refluxing the same in said inert solvent.

Claim 23 is directed to a p-chloro derivative of the claim 22 product and claim 25 defines the process of claim 24 wherein the diamine is ethylenediamine. No additional issues arise as to claims 23 and 25 and they need not be separately considered.

The compound of claim 22, 9B-phen-yl-l,2,3,9B-tetrahydro-5-H~imidazo [2, 1-a] isoindol-5-one, so identified in both Houlihan and appellant’s present application, may be graphically represented

The parent application appellant relied upon discloses 3,4-dihydro-6-phenyl-2,5-benzodiazoein-1 (2H) -one, graphically represented as:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Application of Alan H. Nathan, John A. Hogg and William P. Schneider
328 F.2d 1005 (Customs and Patent Appeals, 1964)
Application of Franklin W. Herrick and Louis H. Bock
344 F.2d 713 (Customs and Patent Appeals, 1965)
George B. Spero v. Howard J. Ringold and George Rosenkranz
377 F.2d 652 (Customs and Patent Appeals, 1967)
Application of Arthur H. Ahlbrecht
435 F.2d 908 (Customs and Patent Appeals, 1971)
Riester v. Kendall
159 F.2d 732 (Customs and Patent Appeals, 1947)
In re Eynde
480 F.2d 1364 (Customs and Patent Appeals, 1973)
In re Wafmouth
486 F.2d 1058 (Customs and Patent Appeals, 1973)

Cite This Page — Counsel Stack

Bluebook (online)
487 F.2d 920, 180 U.S.P.Q. (BNA) 46, 1973 CCPA LEXIS 237, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-sulkowski-ccpa-1973.